INS and cancer: Obesity, hypertension, and cancers in diabetic patients have earlier been reported to reflect insulin-responsive pathology [35,36,37], thereby suggesting that insulin may promote, rather than benefit, non-glycemic disorders, particularly cardiovascular diseases [38], which account for the majority of mortality in patients with T2D [39].